Civic Intelligence

Biocomx

990 • Fiscal year 2017 • EIN 81-4869598

Jan 01, 2017 to Dec 31, 2017

Dana Point, CA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

26th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2017 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2017

Liabilities / Revenue

26th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2017 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2017

Net Margin

95th percentile

64%

Higher net margin than 95% of similar nonprofits.

2017 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2017

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2017

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2017

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2017

Assets

$330,959

No earlier filing loaded for comparison.

Net Assets

$330,959

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

$516,031

No earlier filing loaded for comparison.

Expenses

$185,072

No earlier filing loaded for comparison.

Net Income

$330,959

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$1.0M$500K$0Assets 2017: $330,959Liabilities 2017: $0Net Assets 2017: $330,9592017Assets 2018: $328,793Liabilities 2018: $0Net Assets 2018: $328,7932018Assets 2019: $547,296Liabilities 2019: $0Net Assets 2019: $547,2962019Assets 2020: $926,983Liabilities 2020: $0Net Assets 2020: $926,9832020Assets 2021: $308,692Liabilities 2021: $0Net Assets 2021: $308,6922021Assets 2022: $661,267Liabilities 2022: $0Net Assets 2022: $661,2672022Assets 2023: $0Net Assets 2023: $02023

Highlighted filing

2017

Assets$330,959
Liabilities$0
Net Assets$330,959

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$20M$15M$10M$5.0M$0-$5.0MRevenue 2017: $516,031Expenses 2017: $185,072Net Income 2017: $330,9592017Revenue 2018: $381,052Expenses 2018: $383,218Net Income 2018: -$2,1662018Revenue 2019: $639,148Expenses 2019: $420,647Net Income 2019: $218,5012019Revenue 2020: $9,949,344Expenses 2020: $9,569,657Net Income 2020: $379,6872020Revenue 2021: $15,969,949Expenses 2021: $16,588,240Net Income 2021: -$618,2912021Revenue 2022: $5,516,746Expenses 2022: $5,164,171Net Income 2022: $352,5752022Revenue 2023: $753Expenses 2023: $661,040Net Income 2023: -$660,2872023

Highlighted filing

2017

Revenue$516,031
Expenses$185,072
Net Income$330,959
Filing Detail Status

This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2017 to Dec 31, 2017
Mission and Program Overview

Mission

Train university researches, students, and early stage companies in commercialization of biomedical technologies.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings